Howard Soule

@soulehoward1

Chief Science Officer - Prostate Cancer Foundation. Views expressed are my own.

Santa Monica, CA
Vrijeme pridruživanja: svibanj 2016.

Tweetovi

Blokirali ste korisnika/cu @soulehoward1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @soulehoward1

  1. proslijedio/la je Tweet
    3. velj

    Congratulations to for her promotion to Professor

    Poništi
  2. proslijedio/la je Tweet
    2. velj
    Poništi
  3. proslijedio/la je Tweet
    28. sij
    , , i još njih 5
    Poništi
  4. proslijedio/la je Tweet
    28. sij

    ANNOUNCEMENT: RFA for 2020 Challenge Award Applications to support highly promising team science investigations on metastatic, lethal DEADLINE: 4/17/20 Application Portal opens 2/5/20 View the RFA here:

    Poništi
  5. proslijedio/la je Tweet
    24. sij

    Any considering focal therapy for should read this. A short synopsis by renowned 🌍 expert & the giant 🇺🇸 funder What happens after focal therapy failure can be dire, so think carefully. 🤔

    Poništi
  6. proslijedio/la je Tweet

    It's very enticing to believe that a new form of treatment can avoid all side effects, but that currently is not the case with focal therapy.

    Poništi
  7. proslijedio/la je Tweet
    17. sij

    Are you a soon to be PhD in biomedical sciences open to living in Chicago? I am looking for an enthusiastic postdoc to join my lab for a recently funded DOD project! Prior experience in PCa research not required.

    Poništi
  8. proslijedio/la je Tweet
    16. sij

    Congratulations and well deserved, Hanna!

    Poništi
  9. proslijedio/la je Tweet
    14. sij

    Our next 48-hr will start Tomorrow 1/15/20 at 10am ET! We will be discussing a recently published report on outcomes of localized patients treated with focal therapy, either HIFU or cryoablation. Study led by .

    , , i još njih 4
    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    10. sij

    WOW! Metastasis is incredibly inefficient. At best, 1 in a billion circulating tumor cells lead to clinically evident metastasis. And yet so many deaths each year. Great talk by

    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet
    3. sij

    Accepting applications for the 2 yr fellowship. 15 onc focused faculty, large surg vol, great multiD training, didactics, research and vast supportive alumni network! Information link … Interviews March/April

    Poništi
  12. proslijedio/la je Tweet

    This summer, we are "taking our talents to South Beach," where I'll begin my lab and appt as AD of Community Outreach and Engagement at of THE ! So excited to join a skyrocketing dept/center/institution cc: .

    Prikaži ovu nit
    Poništi
  13. 18. pro 2019.

    There are few activities in life more fulfilling than a scientific dialog without agenda with the brilliant Dr. Pienta I am so proud to call Ken my friend. He fills Dr. Coffey’s shoes so well with deep intellect and leadership. – mjesto: Johns Hopkins Hospital

    Poništi
  14. 16. pro 2019.

    This is an amazing opportunity. MSK IMPACT is changing oncology care in the best ways possible.

    Poništi
  15. 16. pro 2019.

    Thank you for updating your Challenge Award concerning novel imaging for advanced prostate cancer. Strong biomarker research for improved patient care. Perfect cross-disciplinary team. Wish we had taken a team photo! Next time.

    Poništi
  16. 16. pro 2019.

    Thank you and for a thorough update on your Clonal Hematopoiesis Challenge Award. Complex analytical problem solving and potential treatment-related info for patients. Awesome team science. – mjesto: Memorial Sloan Kettering Cancer Center

    Poništi
  17. 16. pro 2019.

    And best wishes to all our friends in Spain! The ornaments on your tree are very special. Happy holidays!!

    Poništi
  18. 15. pro 2019.

    Prostate Cancer Foundation funds research to improve outcomes for patients. Sorry to see us below the NCCN bar . .

    Poništi
  19. proslijedio/la je Tweet
    14. pro 2019.

    Karim Fizazi comments on Tx selection in metastatic prostate cancer with “embarrassment of riches” in mHSPC! Will biomarkers help select patients in the future? Also don’t forget bone health!

    Poništi
  20. proslijedio/la je Tweet
    13. pro 2019.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·